What is the standard approach for screening antidepressants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Depression Screening in Primary Care

Recommended Screening Approach

Use brief validated screening instruments that can be administered in less than 5 minutes, with the simplest and most effective approach being two questions about depressed mood and anhedonia. 1

Screening Methods

Primary Screening Tools

  • Two-question screen (most practical): Ask patients "Over the past 2 weeks, have you felt down, depressed, or hopeless?" and "Over the past 2 weeks, have you felt little interest or pleasure in doing things?" 1

    • This brief approach performs as well as or better than longer instruments 1
    • Can be administered in under 2 minutes 1
  • Standardized instruments (if preferred): Several validated tools are available including PHQ-9, Beck Depression Inventory, Geriatric Depression Scale, Zung Self-Rating Depression Scale, Hospital Anxiety and Depression Scale, General Health Questionnaire, and Center for Epidemiologic Study Depression Scale 1

    • Most have sensitivity of 80-90% and specificity of 70-85% 1
    • Can be completed in less than 5 minutes 1

Critical Follow-Up Requirements

Diagnostic Confirmation

A positive screen is NOT a diagnosis and requires full diagnostic evaluation using DSM criteria. 1

  • Only 24-40% of patients who screen positive will have major depression in primary care settings with 5-10% prevalence 1
  • False-positive screens may represent:
    • Dysthymia or subsyndromal depression 1
    • Comorbid anxiety disorder, substance abuse, panic disorder, PTSD, or grief 1
    • No disorder at all 1

Assessment Components After Positive Screen

  • Establish specific diagnosis (major depression, dysthymia, adjustment disorder) using DSM-IV criteria 1
  • Assess depression severity 1
  • Evaluate for comorbid conditions: anxiety, panic attacks, substance abuse, chronic pain 1
  • Screen for bipolar disorder risk before initiating antidepressants, including detailed psychiatric history and family history of suicide, bipolar disorder, and depression 2

Systems Requirements for Effective Screening

Screening programs only improve patient outcomes when integrated with comprehensive management systems. 1

  • Screening with feedback alone to clinicians increases depression recognition 2-3 fold but does NOT improve treatment rates or clinical outcomes 1
  • Effective programs require:
    • Feedback of screening results to providers 1
    • Provider or patient education 1
    • Access to case management or mental health care 1
    • Telephone follow-up 1
    • Institutional commitment to quality improvement 1

Screening Frequency

  • Optimal screening interval is unknown 1
  • Prioritize recurrent screening for high-risk patients:
    • History of depression 1
    • Unexplained somatic symptoms 1
    • Comorbid panic disorder or generalized anxiety 1
    • Substance abuse 1
    • Chronic pain 1

Special Population Considerations

Children and Adolescents

  • Screening performance is more variable (sensitivity 40-100%, specificity 49-100%) 1
  • Positive predictive value is lower due to lower prevalence 1
  • Routine screening benefits are not established in pediatric primary care 1
  • Remain alert for depression signs but recognize limitations of screening tools 1

Treatment Initiation After Diagnosis

Antidepressant Options

  • For major depression, both tricyclic antidepressants and SSRIs are more effective than placebo 1
  • Newer agents perform similarly to older agents 1
  • In adolescents: SSRIs and cognitive-behavioral therapy are effective, but NOT tricyclic antidepressants 1

Monitoring Requirements

All patients started on antidepressants require close monitoring for:

  • Clinical worsening 2
  • Suicidality 2
  • Unusual behavioral changes, particularly in first few months or with dose changes 2
  • Agitation, anxiety, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, or mania 2

Common Pitfalls

  • Do not rely on screening alone - always confirm diagnosis with full evaluation 1
  • Do not screen without treatment capacity - screening without integrated management systems does not improve outcomes 1
  • Do not miss bipolar disorder - antidepressant monotherapy may precipitate manic episodes in unrecognized bipolar disorder 2
  • Do not assume all positive screens are major depression - many represent other conditions requiring different management 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.